¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"primaquine phosphate sensitivity"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • primaquine sensitivity
    ÇÁ¸®¸¶Äý¹Î°¨µµ
  • primaquine
    ÇÁ¸®¸¶Äý
  • calcium phosphate stone
    ÀλêÄ®½·µ¹
  • glucose-6-phosphate dehydrogenase
    6-ÀλêÆ÷µµ´çÅ»¼ö¼ÒÈ¿¼Ò
  • high energy phosphate compound
    °í¿¡³ÊÁöÀλ꿰ȭÇÕ¹°
  • phosphate
    Àλ꿰
  • phosphate-buffered saline
    Àλ꿰¿ÏÃæ½Ä¿°¼ö
  • cross sensitivity
    ±³Â÷¹Î°¨µµ
  • cellular sensitivity
    ¼¼Æ÷¹Î°¨µµ
  • denervation sensitivity
    Å»½Å°æ¹Î°¨µµ
  • diagnostic sensitivity
    Áø´Ü¹Î°¨µµ
  • disc sensitivity test
    ¿ø¹Ý¹Î°¨°Ë»ç
  • insulin sensitivity index
    Àν¶¸°¹Î°¨Áö¼ö
  • international sensitivity index
    ±¹Á¦¹Î°¨µµÁö¼ö
  • optimal sensitivity
    ÃÖÀû¹Î°¨µµ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • phosphate
    Àλ꿰
  • sensitivity
    1.°¨¼ö¼º, °¨°¢, 2.¹Î°¨µµ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • primaquine sensitivity
    ÇÁ¸®¸¶Äý¹Î°¨µµ
  • primaquine
    ÇÁ¸®¸¶Äý
  • calcium phosphate stone
    ÀλêÄ®½·µ¹
  • phosphate
    Àλ꿰
  • phosphate-buffered saline
    Àλ꿰¿ÏÃæ½Ä¿°¼ö
  • cellular sensitivity
    ¼¼Æ÷¹Î°¨µµ
  • sensitivity control
    °¨µµÁ¶Á¤±â, °¨µµÁ¶Àý
  • sensitivity current
    °¨µµÀü·ù
  • denervation sensitivity
    Å»½Å°æ°ú¹Î, Å»½Å°æ¹Î°¨µµ
  • diagnostic sensitivity
    Áø´Ü¹Î°¨µµ
  • disc sensitivity test
    ¿øÆÇ¹Î°¨°Ë»ç
  • leucine sensitivity hypoglycemia
    ·ù½Å¹Î°¨ÀúÇ÷´çÁõ
  • insulin sensitivity index
    Àν¶¸°°¨¼ºÁö¼ö
  • international sensitivity index
    ±¹Á¦¹Î°¨µµÁö¼ö
  • optimal sensitivity
    ÃÖÀû¹Î°¨µµ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • primaquine sensitivity
    ÇÁ¸®¸¶Äý°ú¹ÎÁõ.
  • primaquine
    ÇÁ¸®¸¶Äý.
  • primaquine
    ÇÁ¸®¸¶Äý
  • ISI => International Sensitivity Index
    ±¹Á¦¿¹¹ÎµµÁö¼ö
  • International Sensitivity Index
    ±¹Á¦¿¹¹ÎµµÁö¼ö
  • International Sensitivity Index=ISI
    ±¹Á¦¹Î°¨µµÁö¼ö
  • TB sensitivity plate
    °áÇÙ±Õ°¨¼ö¼ºÆòÆÇ
  • in vitro sensitivity testing
    ½ÃÇè°ü³» °¨¼ö¼º ½ÃÇè
  • insulin sensitivity
    Àν¶¸°°¨(¼ö)¼º.
  • insulin sensitivity index
    Àν¶¸°°¨¼ºÁö¼ö.
  • insulin sensitivity test
    Àν¶¸°°¨¼º½ÃÇè.
  • radiation sensitivity
    ¹æ»ç¼±°¨¼ö¼º
  • radiation sensitivity test, RST
    ¹æ»ç¼±°¨¼ö¼º°Ë»ç
  • receptor sensitivity
    ¼ö¿ëü °¨¼ö¼º
  • Glucose-6-phosphate dehydrogenase
    ±Û·çÄÚ¿À½º-6-Àλê(×òß«)Å»¼ö¼ÒÈ¿¼Ò(÷­â©áÈý£áÈ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • primaquine sensitivity
    ÇÁ¸®¸¶Äý°ú¹ÎÁõ.
  • primaquine
    ÇÁ¸®¸¶Äý.
  • primaquine
    ÇÁ¸®¸¶Äý
  • cellular sensitivity
    ¼¼Æ÷°¨¼ö¼º
  • contrast sensitivity
    ´ëºñ°¨µµ
  • contrast sensitivity chart
    ´ëºñ°¨µµÇ¥
  • corneal sensitivity
    °¢¸·Áö°¢
  • diagnostic sensitivity
    Áø´ÜÀû ¹Î°¨µµ
  • disc sensitivity test
    ¿øÆÇ°¨¼ö¼º°Ë»ç
  • electrode sensitivity
    Àü±Ø°¨¼ö¼º
  • in vitro sensitivity testing
    ½ÃÇè°ü³» °¨¼ö¼º ½ÃÇè
  • insulin sensitivity
    Àν¶¸°°¨(¼ö)¼º.
  • insulin sensitivity index
    Àν¶¸°°¨¼ºÁö¼ö.
  • insulin sensitivity test
    Àν¶¸°°¨¼º½ÃÇè.
  • leucine sensitivity hypoglycemia
    ·ù½Å°¨¼ö¼º ÀúÇ÷´çÁõ.
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • primaquine
    ÇÁ¸®¸¶Äý
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • primaquine sensitivity
    ÇÁ¸®¸¶Äý °¨¼ö¼º(Êïáôàõ)
  • primaquine
    ÇÁ¸®¸¶Äý
  • oligomycin-sensitivity-conferring factor
    ¿Ã¸®°í¸¶À̽а¨¼ö¼ººÎ¿©ÀÎÀÚ(Êïáôàõݾæ¨ì×í­)
  • sensitivity
    "(¹Î)°¨µµ((ÚÂ)ÊïÓø), °¨¼ö¼º(Êïáôàõ)"
  • active phosphate
    Ȱ¼ºÀλ꿰 (üÀàõ ×òß«ç¤)
  • calcium phosphate gel
    Àλê(×òß«)Ä®½· Á©
  • carbamoyl phosphate
    Ä«¸£¹Ù¸ðÀÏÀλ꿰(×òß«ç¤)
  • creatine phosphate
    Å©·¹¾ÆÆ¾ Àλê(×òß«) (ÔÒ) phosphocreatine
  • dolichol phosphate
    Àλê(×òß«)µ¹¸®ÄÝ
  • fructose-6-phosphate
    ÇÁ¶ôÅ佺-6-Àλê(×òß«)
  • glucose-6-phosphate
    ±Û·çÄÚ½º-6-Àλê(×òß«)
  • glucose-6-phosphate dehydrogenase
    ±Û·çÄÚ½º-6-Àλê(×òß«) µðÇÏÀ̵å·ÎÀú³×À̽º
  • glucose-6-phosphate dehydrogenase deficiency
    ±Û·çÄÚ½º-6-Àλê(×òß«) µðÇÏÀ̵å·ÎÀú³×À̽º °áÇÌ(ÌÀ
  • glycerol phosphate shuttle
    ±Û¸®¼¼·ÑÀλê(×òß«) ºÐ·Î(ÝÂÖØ)
  • high-energy phosphate donor
    °í(ÍÔ)¿¡³ÊÁö ÀÎ»ê°ø¿©ÀÚ(×òß«Íêæ¨í­)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • phosphate
    Àλ꿰
  • physics depth sensitivity
    ¹°¸®Àû±íÀÌ¿¹¹Îµµ
  • radiation sensitivity
    ¹æ»ç¼±°¨¼ö¼º
  • section sensitivity profile(SSP)
    ÀýÆí¹Î°¨Ãø¸é
  • sensitivity
    °¨µµ, °¨¼ö¼º, °¨ÀÀ¼º, ¹Î°¨¼º(µµ)
  • sensitivity of speed
    °¨µµ
  • sensitivity tests
    °¨µµ½ÃÇè, °¨¼ö(¼º)½ÃÇè
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CP candle power; capillary pressure; cardiac pacing; cardiac performance; cardiopulmonary; caudate puta...
CS calf serum; campomelic syndrome; carcinoid syndrome; cardiogenic shock; caries-susceptible; carotid ...
ISI infarct size index; initial slope index; injury severity index; Institute for Scientific Information...
MCS malignant carcinoid syndrome; managed care system; massage of the carotid sinus; mesocaval shunt; me...
G3P, G-3-P glyceraldehyde-3-phosphate; glycerol-3-phosphate
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
PQ Primaquine
P(i) phosphate and inorganic phosphate
Pi 6-phosphate , inorganic phosphate
APC SR APC sensitivity ratio
ASI Anxiety Sensitivity Index
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • primaquine

    primaquine (ÇÁ¸®¸¶Äý

    Ç× ¸»¶óÀ̾ÆÁ¦. Àç¹ßÇÑ 3ÀÏ ¿­ ¸»¶óÀ̾ÆÀÇ Ä¡·á¸¦ À§ÇÏ¿© °æ±¸·Î Åõ¿©ÇÑ´Ù.
  • cellular sensitivity
    ¼¼Æ÷ °¨¼ö¼º
    ¼¼Æ÷°¡ °¨¼ö¼ºÀÌ ÀÖ´Â »óÅ ¶Ç´Â ¼ºÁú·Î¼­, Àڱؿ¡ ´ëÇØ¼­ ºñÁ¤»óÀûÀ¸·Î ¹ÝÀÀÇϰųª ¶Ç´Â ºü¸£°í ¿¹¹ÎÇÏ°Ô ¹ÝÀÀÇÏ´Â »óŸ¦ ³ªÅ¸³»´Â µ¥ Á¾Á¾ »ç¿ëµÈ´Ù.
  • cross sensitivity
    ±³Â÷ °ú¹Î ¹ÝÀÀ
  • dentin sensitivity
    »ó¾ÆÁú °¨¼ö¼º
    Ä¡°ú Áø·á ½Ã »ó¾ÆÁúÀ» ħ¹üÇÒ °æ¿ì ȯÀÚ°¡ µ¿ÅëÀ» ´À³¢´Â Á¤µµ.
  • dietary sensitivity
    À½½Ä¹°¿¡ ´ëÇÑ °ú¹Î¼º
  • disc sensitivity test
    ¿øÆÇ °¨¼ö¼º °Ë»ç
  • local muscle sensitivity
    ±¹¼ÒÀû ±Ù°ú¹Î¼º
  • mechanical sensitivity
    ±â°èÀû °¨µµ
  • optimum sensitivity
    ÃÖÀû °¨µµ
  • oxytocin sensitivity test
    ¿Á½ÃÅä½Å °¨¼ö¼º °Ë»ç
  • pain sensitivity
    µ¿Åë ¹Î°¨µµ
    µ¿Åë ¼ö¿ë±â´Â Ã˰¨À̳ª ¾Ð¹Ú°¨¿¡ ´ëÇØ¼­´Â ¹ÝÀÀÇÏÁö ¾ÊÁö¸¸ Á¶Á÷À» ¼Õ»ó½Ãų Á¤µµÀÇ Ã˰¢¿¡ ´ëÇØ¼­´Â ¹ÝÀÀÇÑ´Ù. µ¿Åë Àü´Þ°è´Â °¡²û µ¿Åë¿¡ °ú¹ÎÇÏ°Ô ¹ÝÀÀÇϴµ¥ À̸¦ µ¿Åë °ú¹ÎÁõÀ̶ó ÇÑ´Ù.
  • radiation sensitivity
    ¹æ»ç¼± °¨¼ö¼º
  • sensitivity
    °¨µµ, °¨¼ö¼º, °¨ÀÀ¼º, ¹Î°¨¼º, ¹Î°¨¼ºµµ, °ú¹Î¼º
    °¨¼ö¼ºÀÌ ÀÖ´Â »óÅ ¶Ç´Â ¼ºÁú·Î¼­, Àڱؿ¡ ´ëÇØ¼­ ºñÁ¤»óÀûÀ¸·Î ¹ÝÀÀÇϰųª ¶Ç´Â ºü¸£°í ¿¹¹ÎÇÏ°Ô ¹ÝÀÀÇÏ´Â »óŸ¦ ³ªÅ¸³»´Â µ¥ Á¾Á¾ »ç¿ëµÈ´Ù.
  • sensitivity disk method
    °¨¼ö¼º µð½ºÅ©¹ý
  • sensitivity range
    ¹Î°¨µµ ¹üÀ§
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
primaquine sensitivity Nonimmunological inborn sensitivity to primaquine, causing haemolysis on exposure to the drug, due to deficiency of glucose-6-phosphate dehydrogenase in red cells.
(05 Mar 2000)
primaquine phosphate 8-[(4-Amino-1-methylbutyl)amino]-6-methoxyquinoline phosphate (1:2);an antimalarial agent especially effective against Plasmodium vivax, terminating relapsing vivax malaria; usually administered with chloroquine.
Primaquine phosphate sensitivity, a sensitivity to primaquine phosphate observed in individuals with glucose-6-phosphate dehydrogenase deficiency.
(05 Mar 2000)
primaquine <drug> An 8 aminoquinoline drug used to treat malaria. Affects the mitochondria of the exo erythrocytic stages (see Plasmodium), but the mechanism is not understood. The most effective drug at preventing spread of all four speciesof human malaria.
(18 Nov 1997)
UDPacetylglucosamine-dolichyl-phosphate acetylglucosamine-1-phosphate transferase <enzyme> Transfers n-acetylglucosamine 1-phosphate from udp-n-acetylglucosamine to dolichyl phosphate, forming n-acetylglucosaminylpyrophosphoryldolichol
Chemical name: udp-glcnac-dolichyl-phosphate glcnac-1-phosphate transerase
Registry number: EC 2.7.8.15
Synonym: n-acetylglucosamine-1-phosphate transferase, dol-p-p-glcnac synthase, dolichol pathway enzyme I, udp-acetylglucosamine-dolichol phosphate acetylglucosamine-1-phosphate transferase, glcnac-dp-1-phosphotransferase, udp-n-acetyl-d-glucosamine-dolichyl-phosphate n-acetyl-d-glucosaminephosphotransferase, dolichol-p-dependent n-acetylglucosamine-1-phosphate transferase, alg7 gene product
(26 Jun 1999)
UDP-GlcNAc-undecaprenyl phosphate N-acetylglucosaminyl 1-phosphate transferase <enzyme> Catalyses transfer of n-acetylglucosamine 1-phosphate from udp-glcnac to undecaprenyl phosphate
Registry number: EC 2.7.8.-
Synonym: glcnac-p-p-und synthase, gpt enzyme
(26 Jun 1999)
acquired sensitivity 1. <immunology> A state of hypersensitivity induced by exposure to a particular antigen (allergen) resulting in harmful immunologic reactions on subsequent exposures, the term is usually used to refer to hypersensitivity to an environmental antigen (atopic allergy or contact dermatitis) or to drug allergy.
The original meaning, now obsolete, included all states of altered immunologic reactivity, immunity as well as hypersensitivity. Gell and Coombs used the term allergic reaction to mean any harmful immunologic reaction causing tissue injury.
2. <study> The medical specialty dealing with diagnosis and treatment of allergic disorders.
(18 Nov 1997)
analytical sensitivity The degree of response to a change in concentration of analyte being measured in an assay; synonymous with the detection limit.
(05 Mar 2000)
antibiotic sensitivity Microbial susceptibility to antibiotics.
See: antibiotic sensitivity test, minimal inhibitory concentration.
(05 Mar 2000)
antibiotic sensitivity test The in vitro testing of bacterial cultures with antibiotics to determine susceptibility of bacteria to antibiotic therapy.
(05 Mar 2000)
pacemaker sensitivity The minimum cardiac activity required to consistently trigger a pulse generator.
(05 Mar 2000)
relative sensitivity The sensitivity of a medical screening test as determined by comparison with the same type of test; e.g., sensitivity of a new serological test relative to sensitivity of an established serological test.
(05 Mar 2000)
chemotherapy drug sensitivity test <investigation> A test to assess a cancerous tissue's response and vulnerability to chemotherapy drugs. This test can help predict a patients response to treatment and suggest which drugs may be useful.
(16 Dec 1997)
microbial sensitivity tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses).
(12 Dec 1998)
photoallergic sensitivity See: photosensitization.
(05 Mar 2000)
phototoxic sensitivity See: photosensitization.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • sensitivity
    ¹Î°¨µµ
  • sensitivity
    ¹Î°¨(¼º);°¨(¼ö)¼º;°¨±¤µµ
  • calcium phosphate
    ÀλêÄ®½·
  • phosphate
    Àλ꿰;¼Ò·®ÀÇ ÀλêÀ» ÇÔÀ¯ÇÑ Åº»ê¼ö
  • phosphate rock
    Àα¤;ÀÎȸ¾Ï
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á